Macromolecular Helicity Induction and Memory in a Poly(biphenylylacetylene) Bearing an Ester Group and Its Application to a Chiral Stationary Phase for High-performance Liquid Chromatography
Compounds and uses thereof for the modulation of hemoglobin
申请人:Global Blood Therapeutics, Inc.
公开号:US10017491B2
公开(公告)日:2018-07-10
Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.
[EN] COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN<br/>[FR] COMPOSÉS ET LEURS UTILISATIONS POUR LA MODULATION DE L'HÉMOGLOBINE
申请人:GLOBAL BLOOD THERAPEUTICS INC
公开号:WO2014150276A1
公开(公告)日:2014-09-25
Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.
Macromolecular Helicity Induction and Memory in a Poly(biphenylylacetylene) Bearing an Ester Group and Its Application to a Chiral Stationary Phase for High-performance Liquid Chromatography
An optically inactive poly(biphenylylacetylene) bearing an ester group at the 4′-position of the pendants formed a preferred-handed helical conformation and biased axial chirality in the pendants through a noncovalent interaction with a chiral alcohol, both of which were retained (memorized) even after removal of the chiral alcohol. The chiral stationary phase for high-performance liquid chromatography, prepared by coating the polymer with macromolecular helicity memory on silica gel, showed good chiral recognition ability towards various racemates.
COMPOUNDS AND USES THEREOF FOR THE MODULATION OF HEMOGLOBIN
申请人:Global Blood Therapeutics, Inc.
公开号:US20170174654A1
公开(公告)日:2017-06-22
Provide herein are compounds and pharmaceutical compositions suitable as modulators of hemoglobin, methods and intermediates for their preparation, and methods for their use in treating disorders mediated by hemoglobin and disorders that would benefit from tissue and/or cellular oxygenation.